AbbVie (ABBV) announced that a new 6-month 45mg Lupron Depot strength has received Health Canada approval for the treatment ...

The diagnosis changed his world, even though he knew it would one day come. More than one doctor had told Greenwood resident Greg Hill that “every man is going to get prostate cancer if he lives long ...

The FDA is reviewing Abbott’s supplemental New Drug Application for a new six-month 45-mg formulation of Lupron Depot (leuprolide acetate for depot suspension) for the palliative treatment of advanced ...

CLAYTON, North Carolina (WTVD) -- Paying attention to your medical bills is crucial as you never know if you'll catch a mistake. Robert Roesemann has been receiving the same Lupron injection for 20 ...

Thanks to a contract manufacturing deal with Takeda gone awry, AbbVie appears to be in line to receive hundreds of millions of dollars in damages. The Delaware Court of Chancery sided with AbbVie ...

National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF). This independent panel of experts in preventive and primary care ...

Dr. Stephanie Berg of the Dana-Farber Cancer Institute and Harvard Medical School discussed the recent EMARK trial which resulted in the FDA’s approval of Xtandi for non-metastatic ...